Brett P Monia Ionis Pharmaceuticals Inc (IONS) insider trading activity

Brett P Monia is Chief Executive Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 180,683 shares of IONS, which is worth approximately $5.9 Million. The most recent transaction as insider was on Feb 03, 2023, when has been sold 49,093 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 181K

3.83% 3M change

3.76% 12M change

Total Value Held $5.9 Million

Brett P Monia Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2023	BUY Grant, award, or other acquisition	-	49,093 Added 22.41%	169,956 Common Stock
Jan 18 2023	SELL Open market or private sale	$989,856 $39.49 p/Share	25,066 Reduced 17.18%	120,863 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	57,267 Added 28.18%	145,929 Common Stock
Apr 01 2022	SELL Open market or private sale	$13,309 $37.49 p/Share	355 Reduced 0.4%	88,662 Common Stock
Feb 28 2022	BUY Other acquisition or disposition	$17,618 $28.37 p/Share	621 Added 0.69%	89,017 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$252,526 $31.44 p/Share	8,032 Reduced 8.33%	88,396 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	16,198 Added 14.38%	96,428 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$593,786 $30.12 p/Share	19,714 Reduced 19.73%	80,230 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	49,475 Added 33.11%	99,944 Common Stock
Aug 31 2021	BUY Other acquisition or disposition	$11,999 $33.8 p/Share	355 Added 0.7%	50,469 Common Stock
Mar 01 2021	SELL Open market or private sale	$12,808 $54.27 p/Share	236 Reduced 0.47%	50,114 Common Stock
Feb 26 2021	BUY Other acquisition or disposition	$11,001 $44.54 p/Share	247 Added 0.49%	50,350 Common Stock
Jan 28 2021	SELL Payment of exercise price or tax liability	$79,261 $60.69 p/Share	1,306 Reduced 2.54%	50,103 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	2,634 Added 4.87%	51,409 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$914,727 $61.28 p/Share	14,927 Reduced 23.43%	48,775 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	-	34,823 Added 35.34%	63,702 Common Stock
Dec 04 2020	SELL Open market or private sale	$1,216,794 $51.04 p/Share	23,840 Reduced 45.22%	28,879 Common Stock
Dec 04 2020	BUY Exercise of conversion of derivative security	$950,501 $39.87 p/Share	23,840 Added 31.14%	52,719 Common Stock
Dec 02 2020	SELL Open market or private sale	$1,085,931 $51.32 p/Share	21,160 Reduced 42.29%	28,879 Common Stock
Dec 02 2020	BUY Exercise of conversion of derivative security	$843,649 $39.87 p/Share	21,160 Added 29.72%	50,039 Common Stock

Also insider at

CGTX

COGNITION THERAPEUTICS INC Healthcare

Director

BPM

Brett P Monia

Chief Executive Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account